pathogen detection
Investigators found that they could increase CNS infection diagnoses by using metagenomic next-generation sequencing to test cerebrospinal fluid samples.
Diagnostics firm QuantaMatrix plans to commercialize the technologies with an automated instrument for pathogen detection, identification, and resistance profiling.
Day Zero Diagnostics Aiming to Bring Whole-Genome Sequencing Pathogen ID/AST to Clinical Labs
Premium
The firm intends to use new funding to move its platform into the clinical trial stage in the pursuit of an FDA-regulated IVD product.
Despite recent struggles, the firm remains optimistic about its position as the first and only direct-from-blood sepsis test system.
University of Pittsburgh researchers showed that real-time pathogen whole-genome sequencing can help curb healthcare-associated infections within a hospital.